Proqr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Proqr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Proqr Today - Breaking & Trending Today

ProQR Announces Second Quarter 2023 Operating and Financial Results

Divestment of sepofarsen and ultevursen ophthalmic programs supports ProQR’s strategic focus on Axiomer® RNA editing platform technology and continued advancement of pipeline€129 M cash and cash equivalents as of June 30, 2023 providing runway into mid-2026 LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing ....

United States , Hans Vitzthum , Robert Stanislaro , Eli Lilly , Sarah Kiely , Company Lilly , Owners Of The Company , Company Euro , Exchange Commission , Chief Executive Officer , Adenosine Deaminase Acting , Biliary Atresia , Primary Sclerosing Cholangitis , North America , Condensed Consolidated Statement , Cash And Equivalents , Rna Editing , Eli Lilly , Ash And Cash Equivalents , Proqr Therapeutics ,

ProQR Therapeutics N : Annual General Meeting Results - Form 6-K

Annual General Meeting Results

On May 17, 2023, ProQR Therapeutics N.V. held its 2023 annual general meeting of shareholders at the offices of Allen & Overy LLP, Apollolaan. | May 17, 2023 ....

Noord Holland , Allen Overy , Annual General Meeting , Management Board , Supervisory Board , Bart Filius , Theresa Heggie , Proqr Therapeuticsnv Stock Exchange , Press Release , Very Prqr Nl0010872495 ,

Proqr Therapeutics N.V. Announces Initial Pipeline Targets and Highlights Axiomer RNA Editing Platform Technology At R&D Event

ProQR today announced AX-0810 for Cholestatic Diseases targeting NTCP and AX-1412 for Cardiovascular Disease targeting B4GALT1 as initial pipeline programs. These programs share several key. | March 30, 2023 ....

Cholestatic Diseases , Cardiovascular Disease , Proqr Therapeuticsnv Stock Exchange , Press Release , Everal Prqr Nl0010872495 ,

Lilly, ProQR To Expand Licensing And Collaboration Deal For New Genetic Medicines

INDIANAPOLIS (dpa-AFX) - Drug maker Eli Lilly and Co. (LLY) announced Thursday that it is expanding its licensing and collaboration agreement with ProQR Therapeutics N.V. (PRQR) focused on the ....

Eli Lilly , More Such Health News ,

ProQR: Q1 Earnings Snapshot

LEIDEN, Netherlands (AP) ProQR Therapeutics NV (PRQR) on Thursday reported a loss of. ....

Western Europe , Zacks Investment Research , C Complete State National , 1 Earnings Snapshot , F Wire , Automated Insights , Wall Street ,